Maxim Group Downgrades Opexa Therapeutics (OPXA) to Hold

October 28, 2016 12:53 PM EDT
Get Alerts OPXA Hot Sheet
Price: $0.91 -1.09%

Rating Summary:
    2 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 32 | New: 34
Trade OPXA Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Maxim Group downgraded Opexa Therapeutics (NASDAQ: OPXA) from Buy to Hold.

For an analyst ratings summary and ratings history on Opexa Therapeutics click here. For more ratings news on Opexa Therapeutics click here.

Shares of Opexa Therapeutics closed at $3.40 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Related Entities

Maxim Group

Add Your Comment